Identification of FRAS1 as a human endometrial carcinoma-derived protein in serum of xenograft model

Gynecologic Oncology

Volumn 127, Issue 2, 2012, Pages 406-411

  Xu, Jing ^a   Min, Wenjiao ^b   Liu, Xinyu ^c   Xie, Chuan ^a   Tang, Jing ^a   Yi, Tao ^a   Li, Zhengyu ^a   Zhao, Xia ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

Author keywords

Biomarker; Endometrial carcinoma; FRAS1; Proteomics; Xenograft model

Indexed keywords

FRAS1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TUMOR XENOGRAFT; WESTERN BLOTTING;

ADULT; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOMETRIAL NEOPLASMS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84867400656     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.07.109     Document Type: Article

References (17)

1. J. Trovik, K.K. Mauland, H.M. Werner, E. Wik, H. Helland, and H.B. Salvesen Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective Gynecol Oncol 125 2012 381 387
2. M. Fogel, M. Huszar, P. Altevogt, and A. Ben-Arie L1 (CD171) as a novel biomarker for ovarian and endometrial carcinomas Expert Rev Mol Diagn 4 2004 455 462
3. J.V. Lacey Jr., G.L. Mutter, B.M. Ronnett, O.B. loffe, M.A. Duggan, and B.B. Rush PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma Cancer Res 68 2008 6014 6020
4. E. Steiner, K. Pollow, D. Hasenclever, W. Schormann, M. Hermes, and M. Schmidt Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer Gynecol Oncol 108 2008 569 576
5. Z. Li, X. Zhao, S. Bai, Z. Wang, L. Chen, and Y. Wei Proteomics identification of cyclophilin A as a potential prognostic factor and therapeutic target in endometrial carcinoma Mol Cell Proteomics 7 2008 1810 1823
6. Z. Li, C. Huang, S. Bai, X. Pan, R. Zhou, and Y. Wei Prognostic evaluation of epidermal fatty acid-binding protein and calcyphosine, two proteins implicated in endometrial cancer using a proteomic approach Int J Cancer 123 2008 2377 2383
7. A. Keller, A.I. Nesvizhskii, E. Kolker, and R. Aebersold Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal Chem 74 2002 5383 5392
8. A.I. Nesvizhskii, A. Keller, E. Kolker, and R. Aebersold A statistical model for identifying proteins by tandem mass spectrometry Anal Chem 75 2003 4646 4658
9. I. Roemer, T. Vogel, A. Otto, I. Fichner, and J. Klose Analysis of mouse beta-haptoglobin chain by lectin affinoblotting detection Electrophoresis 22 2001 3038 3042
10. H.F. Juan, J.H. Chen, W.T. Hsu, S.C. Huang, S.T. Chen, and J. Yi-Chung Lin Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human Proteomics 4 2004 2766 2775
11. G.J. van den Bemd, J. Krijqsveld, T.M. Luider, A.L. van Rijswijk, J.A. Demmers, and G. Jenster Mass spectrometric identification of human prostate cancer-derived proteins in serum of xenograft-bearing mice Mol Cell Proteomics 5 2006 1830 1839
12. F.H. Jansen, J. Krijqsveld, A. van Rijswijk, G.J. van den Bemd, M.S. van den Berg, and W.M. van Weerden Exosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins Mol Cell Proteomics 8 2009 1192 1205
13. J. Sundelin, B.C. Laurent, H. Anundi, L. Traqardh, D. Larhammar, and L. Bjorck Amino acid sequence homologies between rabbit, rat, and human serum retinol-binding proteins J Biol Chem 260 1985 6472 6480
14. E. Pavlakis, R. Chiotaki, and G. Chalepakis The role of Fras1/Frem proteins in the structure and function of basement membrane Int J Biochem Cell Biol 43 2011 487 495
15. A.M. Alazami, R. Shaheen, F. Alzahrani, K. Snape, A. Saggar, and B. Brinkmann FREM1 mutations cause bifid nose, renal agenesis, and anorectal malformations syndrome Am J Hum Genet 85 2009 414 418
16. P. Petrou, A.K. Markrygiannis, and G. Chalepakis The Fras1/Frem family of extracellular matrix proteins: structure, function, and association with Fraser syndrome and the mouse bleb phenotype Connect Tissue Res 49 2008 277 282
17. S. Yoon, S.U. Woo, J.H. Kang, K. Kim, H.J. Shin, and H.S. Gwak NF-κB and STAT3 cooperatively induce IL6 in starved cancer cells Oncogene 2011 10.1038/onc.2011.517